CAFs polarize the tumor immune cells to an immunosuppressive phenotype characterized by arginase expressing M2 macrophages and regulatory T cells, as a result of CAF production of IL-6, IL-10, and TGFβ[12–14]. The gene discussed is TGFB1; the disease is neoplasm.